![Ann Cunningham](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ann Cunningham
Director/Board Member at
VISTAGEN THERAPEUTICS, INC.
Net worth: - $ as of 31/08/2026
Profile
Ms. Ann Cunningham is an Independent Non-Executive Director at Alterity Therapeutics Ltd. and an Independent Director at Vistagen Therapeutics, Inc. She is on the Board of Directors at Alterity Therapeutics Ltd. and Vistagen Therapeutics, Inc. Ms. Cunningham was previously employed as a Vice President-Neurodegenerative Disease by Teva Pharmaceutical Industries Ltd., a Senior Marketing Director by Otsuka America Pharmaceutical, Inc., a Senior Director-Global Brand by Eli Lilly & Co., and a Managing Partner by I3 Strategy Partners LLC.
She received her undergraduate degree from Yale University and an MBA from Stephen M.
Ross School of Business.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 22/07/2026 | 0 ( -.--% ) | - $ | 31/08/2026 |
Ann Cunningham active positions
| Companies | Position | Start |
|---|---|---|
| VISTAGEN THERAPEUTICS, INC. | Director/Board Member | 10/01/2019 |
| ALTERITY THERAPEUTICS LIMITED | Director/Board Member | 17/04/2026 |
Former positions of Ann Cunningham
| Companies | Position | End |
|---|---|---|
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Corporate Officer/Principal | 01/01/2018 |
Otsuka America Pharmaceutical, Inc.
 Otsuka America Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceutical products | Corporate Officer/Principal | 01/01/2015 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 01/01/2013 |
I3 Strategy Partners LLC | Founder | - |
Training of Ann Cunningham
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
83
1st degree connections
8
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
Eli Lilly & Co.
 Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
Teva Pharmaceutical Industries Ltd.
 Teva Pharmaceutical Industries Ltd. Pharmaceuticals: GenericHealth Technology Manufactures and markets generic and proprietary branded pharmaceuticals and active pharmaceutical ingredients | Health Technology |
Alterity Therapeutics Ltd.
 Alterity Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops therapeutic drugs | Health Technology |
Yale University
 Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Otsuka America Pharmaceutical, Inc.
Otsuka America Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceutical products | Health Technology |
Stephen M. Ross School of Business
 Stephen M. Ross School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
VistaGen Therapeutics, Inc.
 VistaGen Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops central nervous system therapies | Health Technology |
I3 Strategy Partners LLC |
- Stock Market
- Insiders
- Ann Cunningham
